Semi-Annual Statement Of Cash Flows

TAKARA BIO INC. - Filing #7352210

Concept 2023-04-01 to
2023-12-31
As at
2023-12-31
As at
2023-03-31
As at
2022-12-31
2022-04-01 to
2022-12-31
As at
2022-03-31
Semi-annual statement of cash flows
Statement of cash flows
Cash flows from operating activities
Profit (loss) before income taxes
500,000,000 JPY
20,318,000,000 JPY
Depreciation
3,259,000,000 JPY
2,976,000,000 JPY
Impairment losses
75,000,000 JPY
JPY
Increase (decrease) in allowance for doubtful accounts
-44,000,000 JPY
-5,000,000 JPY
Interest expenses
18,000,000 JPY
18,000,000 JPY
Increase (decrease) in provision for bonuses
-259,000,000 JPY
-39,000,000 JPY
Decrease (increase) in trade receivables
4,566,000,000 JPY
-9,846,000,000 JPY
Decrease (increase) in inventories
-1,718,000,000 JPY
9,929,000,000 JPY
Increase (decrease) in trade payables
1,167,000,000 JPY
-766,000,000 JPY
Other, net
-49,000,000 JPY
355,000,000 JPY
Subtotal
3,086,000,000 JPY
22,189,000,000 JPY
Interest and dividends received
133,000,000 JPY
80,000,000 JPY
Interest paid
-16,000,000 JPY
-18,000,000 JPY
Income taxes paid
-2,286,000,000 JPY
-9,641,000,000 JPY
Net cash provided by (used in) operating activities
482,000,000 JPY
13,261,000,000 JPY
Cash flows from investing activities
Other, net
-6,000,000 JPY
8,000,000 JPY
Net cash provided by (used in) investing activities
-11,740,000,000 JPY
-9,551,000,000 JPY
Cash flows from financing activities
Dividends paid
-5,048,000,000 JPY
-3,967,000,000 JPY
Net cash provided by (used in) financing activities
-5,184,000,000 JPY
-4,076,000,000 JPY
Effect of exchange rate change on cash and cash equivalents
1,146,000,000 JPY
1,418,000,000 JPY
Net increase (decrease) in cash and cash equivalents
-15,296,000,000 JPY
1,052,000,000 JPY
Cash and cash equivalents
33,761,000,000 JPY
49,058,000,000 JPY
23,212,000,000 JPY
22,160,000,000 JPY

Talk to a Data Expert

Have a question? We'll get back to you promptly.